Izabela Nita (Former)
1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Molecular characterization of two novel cases of complete complement inhibitor Factor I deficiency.
(
- Contribution to journal › Article
- 2010
-
Mark
Analysis of binding sites on complement Factor I that are required for its activity
(
- Contribution to journal › Published meeting abstract
-
Mark
Low plasma levels of monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNF alpha), and vascular endothelial growth factor (VEGF) in patients with alpha1-antitrypsin deficiency-related fibromyalgia
(
- Contribution to journal › Article
-
Mark
Analysis of binding sites on complement factor I that are required for its activity.
(
- Contribution to journal › Article
- 2009
-
Mark
Alpha1-Antitrypsin: New insights into the biological role in vitro and in vivo
(
- Thesis › Doctoral thesis (compilation)
- 2008
-
Mark
{alpha}1-antitrypsin Inhibits the Activity of the Matriptase Catalytic Domain in vitro.
(
- Contribution to journal › Article
- 2007
-
Mark
alpha(1)-Antitrypsin, old dog, new tricks - alpha 1-Antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevatin cAMP
(
- Contribution to journal › Article
-
Mark
alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.
(
- Contribution to journal › Article
- 2006
-
Mark
alpha1-Antitrypsin inhibits Moraxella catarrhalis MID protein-induced tonsillar B cell proliferation and IL-6 release.
(
- Contribution to journal › Article
- 2005
-
Mark
Prolastin, a pharmaceutical preparation of purified human alpha 1-antitrypsin, blocks endotoxin-mediated cytokine release
(
- Contribution to journal › Article